Immunohistology of Non-Hodgkin Lymphoma

Diagnostic Immunohistochemistry, Second Edition

Volumn , Issue , 2006, Pages 137-161

  Gocke, Christopher D ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902400114     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06652-8.50011-9     Document Type: Chapter

References (273)

1. NL Harris, ES Jaffe, H Stein, et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5), 1361-1392.
2. S Poppema (1996) Lymphoma classification proposal. Blood 87(1), 412-413.
3. CJ Meijer, P van der Valk, PC de Bruin, et al. (1995) The revised European-American lymphoma (REAL) classification of non-Hodgkin's lymphoma: a missed opportunity? Blood 85(7), 1971-1972.
4. SA Rosenberg (1994) Classification of lymphoid neoplasms. Blood 84(5), 1359-1360.
5. S Pittaluga, L Bijnens, I Teodorovic, et al. (1996) Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. Blood 87(10), 4358-4367.
6. [No authors listed] (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89(11), 3909-3918.
7. ES Jaffe, NL Harris, H Stein, et al. (Eds) (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues Lyon: IARC Press
8. ES Jaffe, NL Harris, J Diebold, et al. (1998) World Health Organization Classification of lymphomas: a work in progress. Ann Oncol 9(Suppl 5), S25-S30.
9. NL Harris, ES Jaffe, J Diebold, et al. (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Mod Pathol 13(2), 193-207.
10. SL Abbondanzo (1999) Paraffin immunohistochemistry as an adjunct to hematopathology. Ann Diagn Pathol 3(5), 318-327.
11. PG Chu, KL Chang, DA Arber, et al. (1999) Practical applications of immunohistochemistry in hematolymphoid neoplasms. Ann Diagn Pathol 3(2), 104-133.
12. VI Leucocyte Typing (1997) White Cell Differentiation Antigens. T Kishimoto, S Goyert, H Kikutani, et al., (Eds) Sixth International Workshop and Conference; 1997 Kobe, Japan: Garland Publishers Inc
13. SA Pileri, G Roncador, C Ceccarelli, et al. (1997) Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 183(1), 116-123.
14. SR Shi, RJ Cote and CR Taylor (1997) Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 45(3), 327-343.
15. SR Shi, ME Key and KL Kalra (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39(6), 741-748.
16. K Johnson, S Chensue and P Ward (1999) Immunopathology. E Rubin, J Farber (Eds) Pathology 3rd edn Philadelphia: Lippincott-Raven 104-153.
17. G Inghirami and D Knowles (1992) The immune system: structure and function. D Knowles (Eds) Neoplastic hematopathology Baltimore: Williams & Wilkins 27-72.
18. C Benoist and D Mathis (1999) T lymphocyte differentiation and biology. W Paul (Eds) Fundamental immunology 4th edn Philadelphia: Lippincott-Raven Publishers 367-410.
19. A DeFranco (1999) B lymphocyte activation. W Paul (Eds) Fundamental Immunology 4th edn Philadelphia: Lippincott-Raven Publishers 225-261.
20. F Melchers and A Rolink (1999) B-lymphocyte development and biology. W Paul (Eds) Fundamental immunology 4th edn Philadelphia: Lippincott-Raven Publishers 183-224.
21. CM Rudin and CB Thompson (1998) B-cell development and maturation. Semin Oncol 25(4), 435-446.
22. K Lennert and A Feller (1992) Histopathology of non-Hodgkin's lymphomas 2nd edn Berlin: Springer-Verlag
23. R Lukes and R Collins (1974) A functional approach to the classification of malignant lymphoma. Recent Results Cancer Res 46 18-30.
24. RJ Lukes and RD Collins (1974) Immunologic characterization of human malignant lymphomas. Cancer 34(4 Suppl), 1488-1503.
25. M Stetler-Stevenson, L Medieros and E Jaffe (1995) Immunophenotypic methods and findings in the diagnosis of lymphoproliferative diseases. E Jaffe (Eds) Surgical pathology of the lymph nodes and related organs 2nd edn Philadelphia: WB Saunders 22-57.
26. L Nitschke and T Tsubata (2004) Molecular interactions regulate BCR signal inhibition by CD22 and CD72. Trends Immunol 25(10), 543-550.
27. DY Mason, JL Cordell, MH Brown, et al. (1995) CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood 86(4), 1453-1459.
28. K Dorshkind (2000) Chapter 8 – B-Cell Development. R Hoffman (Eds) Hematology: basic principles and practice 3rd edn New York: Churchill Livingstone xxxi. 2584 p., [2524] p. of plates
29. A Chizuka, Y Kanda, Y Nannya, et al. (2002) The diagnostic value of kappa/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma. Clin Lab Haematol 24(1), 33-36.
30. MK Samoszuk, M Krailo, QH Yan, et al. (1985) Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas. Diagn Immunol 3(3), 133-138.
31. NS Aguilera, SB Kapadia, MA Nalesnik, et al. (1995) Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol 8(5), 503-508.
32. RC Beck, RR Tubbs, M Hussein, et al. (2003) Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphoma. Diagn Mol Pathol 12(1), 14-20.
33. LH Lee, A Cioc and GJ Nuovo (2004) Determination of light chain restriction in fine-needle aspiration-type preparations of B-cell lymphomas by mRNA in situ hybridization. Appl Immunohistochem Mol Morphol 12(3), 252-258.
34. JH Pringle, AK Ruprai, L Primrose, et al. (1990) In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten-labelled oligonucleotide probes. J Pathol 162(3), 197-207.
35. R Malisius, H Merz, B Heinz, et al. (1997) Constant detection of CD2, CD3, CD4, and CD5 in fixed and paraffin-embedded tissue using the peroxidase-mediated deposition of biotin-tyramide. J Histochem Cytochem 45(12), 1665-1672.
36. WR Macon and KE Salhany (1998) T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry. Am J Clin Pathol 109(5), 610-617.
37. DM Dorfman and A Shahsafaei (2002) CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas. Hum Pathol 33(3), 330-334.
38. AP Weng, A Shahsafaei and DM Dorfman (2003) CXCR4/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1- Th2+ immunophenotype. Am J Clin Pathol 119(3), 424-430.
39. LJ Picker, LM Weiss, LJ Medeiros, et al. (1987) Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 128(1), 181-201.
40. G Delsol, L Lamant, B Mariame, et al. (1997) A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 89(5), 1483-1490.
41. B Falini, B Bigerna, M Fizzotti, et al. (1998) ALK expression defines a distinct group of T/null lymphomas (‘ALK lymphomas’) with a wide morphological spectrum. Am J Pathol 153(3), 875-886.
42. B Falini, M Fizzotti, S Pileri, et al. (1997) Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol 8(Suppl 2), 101-104.
43. D Arber and L Weiss (1995) CD57: a review. Appl Immunohistochem 3 137-152.
44. G Frizzera, CD Wu and G Inghirami (1999) The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update. Am J Clin Pathol 111(1 Suppl 1), S13-S39.
45. DB Troxel and JD Sabella (1994) Problem areas in pathology practice. Uncovered by a review of malpractice claims. Am J Surg Pathol 18(8), 821-831.
46. R Lai, DA Arber, KL Chang, et al. (1998) Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11(9), 864-869.
47. T Wang, J Lasota, CA Hanau, et al. (1995) Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value. APMIS 103(9), 655-662.
48. A Dogan, E Bagdi, P Munson, et al. (2000) CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24(6), 846-852.
49. AB Gelb, RV Rouse, RF Dorfman, et al. (1994) Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. Am J Clin Pathol 102(6), 825-834.
50. G Browne, B Tobin, DN Carney, et al. (1991) Aberrant MT2 positivity distinguishes follicular lymphoma from reactive follicular hyperplasia in B5- and formalin-fixed paraffin sections. Am J Clin Pathol 96(1), 90-94.
51. JF Emile, J Wechsler, N Brousse, et al. (1995) Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples. Am J Surg Pathol 19(6), 636-641.
52. CS Ng, JK Chan, PK Hui, et al. (1989) Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol 20(12), 1145-1154.
53. B Falini, S Pileri, H Stein, et al. (1990) Variable expression of leucocyte-common (CD45) antigen in CD30 (Ki1)-positive anaplastic large-cell lymphoma: implications for the differential diagnosis between lymphoid and nonlymphoid malignancies. Hum Pathol 21(6), 624-629.
54. M Clavio, E Rossi, M Truini, et al. (1996) Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients. Leuk Lymphoma 22(3-4), 319-327.
55. PC de Bruin, RC Beljaards, P van Heerde, et al. (1993) Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23(2), 127-135.
56. H Battifora (1991) Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol 96(5), 669-671.
57. JR Anderson, JO Armitage and DD Weisenburger (1998) Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 9(7), 717-720.
58. LJ Medeiros (1995) Intermediate and high-grade diffuse non-Hodgkin's lymphomas in the Working Formulation. E Jaffe (Eds) Surgical pathology of the lymph nodes and related organs 2nd edn Philadelphia: WB Saunders 283-343.
59. LM Weiss, JM Bindl, VJ Picozzi, et al. (1986) Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 67(2), 474-478.
60. J Cossman, TM Chused, RI Fisher, et al. (1983) Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43(9), 4486-4490.
61. RM Braziel, T Keneklis, JA Donlon, et al. (1983) Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma. Am J Clin Pathol 80(5), 655-659.
62. M Ozdemirli, JC Fanburg-Smith, DP Hartmann, et al. (1998) Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. Am J Surg Pathol 22(7), 795-804.
63. S Iravani, TP Singleton, CW Ross, et al. (1999) Precursor B lymphoblastic lymphoma presenting as lytic bone lesions. Am J Clin Pathol 112(6), 836-843.
64. S Chimenti, R Fink-Puches, K Peris, et al. (1999) Cutaneous involvement in lymphoblastic lymphoma. J Cutan Pathol 26(8), 379-385.
65. RA Soslow, LR Zukerberg, NL Harris, et al. (1997) BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma. Mod Pathol 10(8), 810-817.
66. RA Soslow, RN Baergen and RA Warnke (1999) B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer 85(12), 2648-2654.
67. P Van Eyken, C De Wolf-Peeters, J Van den Oord, et al. (1987) Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: an immunohistochemical study. J Pathol 151(4), 257-261.
68. JK Taubenberger, DE Cole, M Raffeld, et al. (1991) Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. Arch Pathol Lab Med 115(4), 338-342.
69. PB Robertson, RS Neiman, S Worapongpaiboon, et al. (1997) 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. Mod Pathol 10(4), 277-282.
70. M Riopel, PS Dickman, MP Link, et al. (1994) MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 25(4), 396-399.
71. K Sheibani, BN Nathwani, CD Winberg, et al. (1987) Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer 60(2), 183-190.
72. WY Tsang, JK Chan, CS Ng, et al. (1996) Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 20(2), 202-210.
73. L Mullauer, I Mosberger and A Chott (1998) Fas ligand expression in nodal non-Hodgkin's lymphoma. Mod Pathol 11(4), 369-375.
74. RA Soslow, V Bhargava and RA Warnke (1997) MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 28(10), 1158-1165.
75. ED de Leon, S Alkan, JC Huang, et al. (1998) Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes. Mod Pathol 11(11), 1046-1051.
76. R Lai, LM Weiss, KL Chang, et al. (1999) Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas. Am J Clin Pathol 111(4), 488-494.
77. S Kumar, GA Green, J Teruya-Feldstein, et al. (1996) Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol 9(9), 925-929.
78. O Kaufmann, B Flath, E Spath-Schwalbe, et al. (1997) Immunohistochemical detection of CD5 with monoclonal antibody 4C7 on paraffin sections. Am J Clin Pathol 108(6), 669-673.
79. DM Dorfman and A Shahsafaei (1997) Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Mod Pathol 10(9), 859-863.
80. JC Huang, WG Finn, CL Goolsby, et al. (1999) CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. Am J Clin Pathol 111(1), 123-130.
81. A Orazi, G Cattoretti, N Polli, et al. (1991) Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies. Eur J Haematol 47(1), 28-35.
82. N Singh and DH Wright (1997) The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas. J Clin Pathol 50(1), 16-21.
83. NS Aguilera, WS Chu, JA Andriko, et al. (1998) Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma. Hum Pathol 29(10), 1134-1139.
84. DM Dorfman and GS Pinkus (1994) Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 7(3), 326-331.
85. CH Dunphy, SE Wheaton and SL Perkins (1997) CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Mod Pathol 10(8), 818-822.
86. P Watson, KM Wood, A Lodge, et al. (2000) Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma. Histopathology 36(2), 145-150.
87. SH Swerdlow, WI Yang, LR Zukerberg, et al. (1995) Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Hum Pathol 26(9), 999-1004.
88. WI Yang, LR Zukerberg, T Motokura, et al. (1994) Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145(1), 86-96.
89. MA Vasef, LJ Medeiros, C Koo, et al. (1997) Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am J Clin Pathol 108(3), 302-307.
90. LR Zukerberg, WI Yang, A Arnold, et al. (1995) Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 103(6), 756-760.
91. MD Raible, ED Hsi and S Alkan (1999) Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders. Am J Clin Pathol 112(1), 101-107.
92. M Aguilar-Santelises, KP Magnusson, KG Wiman, et al. (1994) Progressive B-cell chronic lymphocytic leukaemia frequently exhibits aberrant p53 expression. Int J Cancer 58(4), 474-479.
93. D Jones, RJ Benjamin, A Shahsafaei, et al. (2000) The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 95(2), 627-632.
94. JH Admirand, GZ Rassidakis, LV Abruzzo, et al. (2004) Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 17(8), 954-961.
95. SJ Sup, R Domiati-Saad, TW Kelley, et al. (2004) ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL/SLL. Am J Clin Pathol 122(4), 582-587.
96. M Crespo, F Bosch, N Villamor, et al. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348(18), 1764-1775.
97. A Wiestner, A Rosenwald, TS Barry, et al. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101(12), 4944-4951.
98. LZ Rassenti, L Huynh, TL Toy, et al. (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351(9), 893-901.
99. J Carreras, N Villamor, L Colomo, et al. (2005) Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms. J Pathol 205(4), 507-513.
100. JM Bennett, D Catovsky, MT Daniel, et al. (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 42(6), 567-584.
101. N de Melo, E Matutes, I Cordone, et al. (1992) Expression of Ki-67 nuclear antigen in B and T cell lymphoproliferative disorders. J Clin Pathol 45(8), 660-663.
102. NL Harris and AK Bhan (1985) B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16(8), 829-837.
103. PA Hall, AJ D'Ardenne, MA Richards, et al. (1987) Lymphoplasmacytoid lymphoma: an immunohistological study. J Pathol 153(3), 213-223.
104. LR Zukerberg, LJ Medeiros, JA Ferry, et al. (1993) Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100(4), 373-385.
105. JA Tworek, TP Singleton, B Schnitzer, et al. (1998) Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol 110(5), 582-589.
106. M Chilosi, F Adami, M Lestani, et al. (1999) CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol 12(12), 1101-1106.
107. PL Nguyen, NL Harris, J Ritz, et al. (1996) Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Am J Pathol 148(3), 847-853.
108. D Catovsky and E Matutes (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol 36(2), 148-154.
109. RD Hammer, AD Glick, JP Greer, et al. (1996) Splenic marginal zone lymphoma. A distinct B-cell neoplasm. Am J Surg Pathol 20(5), 613-626.
110. L Baldini, NS Fracchiolla, LM Cro, et al. (1994) Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin. Blood 84(1), 270-278.
111. E Matutes, R Morilla, K Owusu-Ankomah, et al. (1994) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma 14(Suppl 1), 57-61.
112. E Matutes, R Morilla, K Owusu-Ankomah, et al. (1994) The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood 83(6), 1558-1562.
113. R Rosso, RS Neiman, M Paulli, et al. (1995) Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. Hum Pathol 26(1), 39-46.
114. MA Piris, M Mollejo, E Campo, et al. (1998) A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma. Histopathology 33(3), 230-239.
115. M Mollejo, E Lloret, J Menarguez, et al. (1997) Lymph node involvement by splenic marginal zone lymphoma: morphological and immunohistochemical features. Am J Surg Pathol 21(7), 772-780.
116. CD Wu, CL Jackson and LJ Medeiros (1996) Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases. Am J Clin Pathol 105(3), 277-285.
117. J Pawade, BS Wilkins and DH Wright (1995) Low-grade B-cell lymphomas of the splenic marginal zone: a clinicopathological and immunohistochemical study of 14 cases. Histopathology 27(2), 129-137.
118. E Savilo, E Campo, M Mollejo, et al. (1998) Absence of cyclin D1 protein expression in splenic marginal zone lymphoma. Mod Pathol 11(7), 601-606.
119. AJ Janckila, EM Cardwell, LT Yam, et al. (1995) Hairy cell identification by immunohistochemistry of tartrate-resistant acid phosphatase. Blood 85(10), 2839-2844.
120. AJ Janckila, SC Lear, AW Martin, et al. (1996) Epitope enhancement for immunohistochemical demonstration of tartrate-resistant acid phosphatase. J Histochem Cytochem 44(3), 235-244.
121. JD Hoyer, CY Li, LT Yam, et al. (1997) Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders. Am J Clin Pathol 108(3), 308-315.
122. R Stroup and K Sheibani (1992) Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: an immunohistochemical evaluation of 66 cases. Hum Pathol 23(2), 172-177.
123. A Kreft, G Busche, J Bernhards, et al. (1997) Immunophenotype of hairy-cell leukaemia after cold polymerization of methyl-methacrylate embeddings from 50 diagnostic bone marrow biopsies. Histopathology 30(2), 145-151.
124. GH Segal, MH Stoler, AJ Fishleder, et al. (1991) Reliable and cost-effective paraffin section immunohistology of lymphoproliferative disorders. Am J Surg Pathol 15(11), 1034-1041.
125. D Hakimian, MS Tallman, C Kiley, et al. (1993) Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82(6), 1798-1802.
126. H Hounieu, SM Chittal, T al Saati, et al. (1992) Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol 98(1), 26-33.
127. M Ohsawa, H Kanno, T Machii, et al. (1994) Immunoreactivity of neoplastic and non-neoplastic monocytoid B lymphocytes for DBA.44 and other antibodies. J Clin Pathol 47(10), 928-932.
128. H Yaziji, AJ Janckila, SC Lear, et al. (1995) Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 104(4), 397-402.
129. F Bosch, E Campo, P Jares, et al. (1995) Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 91(4), 1025-1030.
130. CJ de Boer, JC Kluin-Nelemans, E Dreef, et al. (1996) Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol 7(3), 251-256.
131. V Costes, V Magen, E Legouffe, et al. (1999) The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens. Hum Pathol 30(12), 1405-1411.
132. A Vallario, M Chilosi, F Adami, et al. (1999) Human myeloma cells express the CD38 ligand CD31. Br J Haematol 105(2), 441-444.
133. MS Hamilton, HF Barker, J Ball, et al. (1991) Normal and neoplastic human plasma cells express bcl-2 antigen. Leukemia 5(9), 768-771.
134. TC Diss, AC Wotherspoon, P Speight, et al. (1995) B-cell monoclonality, Epstein-Barr virus, and t(14;18) in myoepithelial sialadenitis and low-grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol 19(5), 531-536.
135. MF Baldassano, EM Bailey, JA Ferry, et al. (1999) Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol 23(1), 88-96.
136. F Berger, P Felman, C Thieblemont, et al. (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95(6), 1950-1956.
137. JE Arends, FJ Bot, IA Gisbertz, et al. (1999) Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis. Histopathology 35(3), 209-215.
138. JA Ferry, WI Yang, LR Zukerberg, et al. (1996) CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol 105(1), 31-37.
139. M Ashton-Key, SC Biddolph, H Stein, et al. (1995) Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology 26(1), 75-78.
140. L Cerroni, S Signoretti, G Hofler, et al. (1997) Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 21(11), 1307-1315.
141. R Chetty, JJ O'Leary, SC Biddolph, et al. (1995) Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas. J Clin Pathol 48(3), 239-241.
142. S Nakamura, K Akazawa, N Kinukawa, et al. (1996) Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum Pathol 27(3), 225-233.
143. E Navratil, P Gaulard, P Kanavaros, et al. (1995) Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue. J Clin Pathol 48(1), 18-21.
144. K Omonishi, T Yoshino, I Sakuma, et al. (1998) bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Mod Pathol 11(2), 181-185.
145. S Nakamura, K Akazawa, T Yao, et al. (1995) A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 76(8), 1313-1324.
146. PG Isaacson (1999) Gastrointestinal lymphomas of T- and B-cell types. Mod Pathol 12(2), 151-158.
147. GG Davis, JC York, AD Glick, et al. (1992) Plasmacytic differentiation in parafollicular (monocytoid) B-cell lymphoma. A study of 12 cases. Am J Surg Pathol 16(11), 1066-1074.
148. H Nizze, SB Cogliatti, C von Schilling, et al. (1991) Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology 18(5), 403-414.
149. PJ Kurtin, KS Hobday, S Ziesmer, et al. (1999) Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. Am J Clin Pathol 112(3), 319-329.
150. E Ballesteros, BM Osborne and AY Matsushima (1998) CD5+ low-grade marginal zone B-cell lymphomas with localized presentation. Am J Surg Pathol 22(2), 201-207.
151. J Dierlamm, S Pittaluga, I Wlodarska, et al. (1996) Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87(1), 299-307.
152. E Campo, R Miquel, L Krenacs, et al. (1999) Primary nodal marginal zone lymphomas of splenic and MALT type. Am J Surg Pathol 23(1), 59-68.
153. AM Hernandez, BN Nathwani, D Nguyen, et al. (1995) Nodal benign and malignant monocytoid B cells with and without follicular lymphomas: a comparative study of follicular colonization, light chain restriction, bcl-2, and t(14;18) in 39 cases. Hum Pathol 26(6), 625-632.
154. V Levy, C Miller, HP Koeffler, et al. (1996) p53 in lymphomas of mucosal-associated lymphoid tissues. Mod Pathol 9(3), 245-248.
155. L Baldini, A Guffanti, L Cro, et al. (1997) Poor prognosis in non-villous splenic marginal zone cell lymphoma is associated with p53 mutations. Br J Haematol 99(2), 375-378.
156. GG McIntosh, AJ Lodge, P Watson, et al. (1999) NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154(1), 77-82.
157. MJ Contos, MJ Kornstein, DJ Innes, et al. (1992) The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections. Mod Pathol 5(6), 631-633.
158. M Ashton-Key, TC Diss, PG Isaacson, et al. (1995) A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma. Histopathology 27(6), 501-508.
159. K Cooper and Z Haffajee (1997) bcl-2 and p53 protein expression in follicular lymphoma. J Pathol 182(3), 307-310.
160. P Gaulard, MF d'Agay, M Peuchmaur, et al. (1992) Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140(5), 1089-1095.
161. PL Nguyen, LR Zukerberg, WF Benedict, et al. (1996) Immunohistochemical detection of p53, bcl-2, and retinoblastoma proteins in follicular lymphoma. Am J Clin Pathol 105(5), 538-543.
162. BF Skinnider, DE Horsman, B Dupuis, et al. (1999) Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. Hum Pathol 30(7), 803-808.
163. MD Logsdon, RE Meyn Jr, PC Besa, et al. (1999) Apoptosis and the Bcl-2 gene family – patterns of expression and prognostic value in stage I and II follicular center lymphoma. Int J Radiat Oncol Biol Phys 44(1), 19-29.
164. JJ Goates, OW Kamel, DP LeBrun, et al. (1994) Floral variant of follicular lymphoma. Immunological and molecular studies support a neoplastic process. Am J Surg Pathol 18(1), 37-47.
165. F Pezzella, M Jones, E Ralfkiaer, et al. (1992) Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 65(1), 87-89.
166. G Cattoretti, CC Chang, K Cechova, et al. (1995) BCL-6 protein is expressed in germinal-center B cells. Blood 86(1), 45-53.
167. Z Szereday, B Csernus, M Nagy, et al. (2000) Somatic mutation of the 5′ noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. Am J Pathol 156(3), 1017-1024.
168. MB Moller, O Nielsen and NT Pedersen (1999) Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities. Mod Pathol 12(11), 1010-1016.
169. OW Kamel, AB Gelb, RB Shibuya, et al. (1993) Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 142(2), 541-546.
170. JY Scoazec, F Berger, JP Magaud, et al. (1989) The dendritic reticulum cell pattern in B cell lymphomas of the small cleaved, mixed, and large cell types: an immunohistochemical study of 48 cases. Hum Pathol 20(2), 124-131.
171. M Miettinen (1992) CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Arch Pathol Lab Med 116(11), 1197-1201.
172. M Piris, KC Gatter and DY Mason (1991) CD30 expression in follicular lymphoma. Histopathology 18(1), 25-29.
173. R Chetty, G Echezarreta, M Comley, et al. (1995) Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma. J Clin Pathol 48(11), 1035-1038.
174. PJ Kurtin (1998) Mantle cell lymphoma. Adv Anat Pathol 5(6), 376-398.
175. A Lavergne, JP Brouland, E Launay, et al. (1994) Multiple lymphomatous polyposis of the gastrointestinal tract. An extensive histopathologic and immunohistochemical study of 12 cases. Cancer 74(11), 3042-3050.
176. S Pittaluga, I Wlodarska, MS Stul, et al. (1995) Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 26(1), 17-24.
177. M Fraga, E Lloret, L Sanchez-Verde, et al. (1995) Mucosal mantle cell (centrocytic) lymphomas. Histopathology 26(5), 413-422.
178. Y Yatabe, R Suzuki, K Tobinai, et al. (2000) Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood 95(7), 2253-2261.
179. S Kumar, L Krenacs, T Otsuki, et al. (1996) bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. Am J Clin Pathol 105(6), 737-743.
180. TP Singleton, MM Anderson, CW Ross, et al. (1999) Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol 111(4), 495-500.
181. K Gronbaek, T Nedergaard, MK Andersen, et al. (1998) Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia 12(8), 1266-1271.
182. CC Chang, YC Liu, RP Cleveland, et al. (2000) Expression of c-Myc and p53 correlates with clinical outcome in diffuse large B-cell lymphomas. Am J Clin Pathol 113(4), 512-518.
183. DC Louie, K Offit, R Jaslow, et al. (1995) p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86(8), 2892-2899.
184. L Hernandez, T Fest, M Cazorla, et al. (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 87(8), 3351-3359.
185. MD Fiel-Gan, LM Almeida, DC Rose, et al. (1999) Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma. Int J Mol Med 3(4), 373-379.
186. H Stein, K Lennert, AC Feller, et al. (1984) Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res 42 67-147.
187. RS Doggett, GS Wood, S Horning, et al. (1984) The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 115(2), 245-252.
188. M Taniguchi, K Oka, A Hiasa, et al. (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91(4), 1145-1151.
189. JM Fang, WG Finn, JW Hussong, et al. (1999) CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma. Mod Pathol 12(3), 295-300.
190. M Martinka, T Comeau, A Foyle, et al. (1997) Prognostic significance of t(14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clin Invest Med 20(6), 364-370.
191. RD Gascoyne, SA Adomat, S Krajewski, et al. (1997) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90(1), 244-251.
192. RD Gascoyne, M Krajewska, S Krajewski, et al. (1997) Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma. Blood 90(8), 3173-3178.
193. P Drillenburg, VJ Wielenga, MH Kramer, et al. (1999) CD44 expression predicts disease outcome in localized large B cell lymphoma. Leukemia 13(9), 1448-1455.
194. S Donoghue, HS Baden, I Lauder, et al. (1999) Immunohistochemical localization of caspase-3 correlates with clinical outcome in B-cell diffuse large-cell lymphoma. Cancer Res 59(20), 5386-5391.
195. LM Weiss, JG Strickler, LJ Medeiros, et al. (1987) Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibody. Hum Pathol 18(11), 1155-1159.
196. HFJ Frierson, FJ Bellafiore, MJ Gaffey, et al. (1994) Cytokeratin in anaplastic large cell lymphoma. Mod Pathol 7(3), 317-321.
197. PC de Bruin, HJ Gruss, P van der Valk, et al. (1995) CD30 expression in normal and neoplastic lymphoid tissue: biological aspects and clinical implications. Leukemia 9(10), 1620-1627.
198. J Krishnan, K Wallberg and G Frizzera (1994) T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 18(5), 455-465.
199. S Suster (1999) Primary large-cell lymphomas of the mediastinum. Semin Diagn Pathol 16(1), 51-64.
200. RE Davis, RF Dorfman and RA Warnke (1990) Primary large-cell lymphoma of the thymus: a diffuse B-cell neoplasm presenting as primary mediastinal lymphoma. Hum Pathol 21(12), 1262-1268.
201. J Rodriguez, WC Pugh, JE Romaguera, et al. (1994) Primary mediastinal large cell lymphoma. Hematol Oncol 12(4), 175-184.
202. J Rodriguez, WC Pugh, JE Romaguera, et al. (1994) Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Ann Oncol 5(9), 847-849.
203. JP Higgins and RA Warnke (1999) CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 112(2), 241-247.
204. DM Knowles (1999) Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12(2), 200-217.
205. I Green, E Espiritu, M Ladanyi, et al. (1995) Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Mod Pathol 8(1), 39-45.
206. RG Nador, E Cesarman, A Chadburn, et al. (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88(2), 645-656.
207. JA DiGiuseppe, WG Nelson, EJ Seifter, et al. (1994) Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol 12(12), 2573-2579.
208. JA Ferry, NL Harris, LJ Picker, et al. (1988) Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol 1(6), 444-452.
209. P Domizio, PA Hall, F Cotter, et al. (1989) Angiotropic large cell lymphoma (ALCL): morphological, immunohistochemical and genotypic studies with analysis of previous reports. Hematol Oncol 7(3), 195-206.
210. M Kanda, J Suzumiya, K Ohshima, et al. (1999) Intravascular large cell lymphoma: clinicopathological, immunohistochemical and molecular genetic studies. Leuk Lymphoma 34(5-6), 569-580.
211. T Rudinger, G Ott, M Ott, et al. (2000) Reply to: B-cell anaplastic large cell lymphoma – the forgotten entity. Am J Surg Pathol 24 159-160.
212. J Suzumiya, K Ohshima, M Kikuchi, et al. (1997) Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections: a useful method for the diagnosis of lymphoblastic lymphoma. J Pathol 182(1), 86-91.
213. D Guinee Jr, E Jaffe, D Kingma, et al. (1994) Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. Am J Surg Pathol 18(8), 753-764.
214. R Chetty, K Pulford, M Jones, et al. (1996) An immunohistochemical study of TAL-1 protein expression in leukaemias and lymphomas with a novel monoclonal antibody, 2TL 242. J Pathol 178(3), 311-315.
215. KW Sykora, J Tomeczkowski and A Reiter (1997) C-kit receptors in childhood malignant lymphoblastic cells. Leuk Lymphoma 25(3-4), 201-216.
216. J Chan and W Tsang (1996) Reactive lymphadenopathies. L Weiss (Eds) Pathology of lymph nodes New York: Churchill Livingstone 81-167.
217. AC Chan, JW Ho, AK Chiang, et al. (1999) Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology 34(1), 16-24.
218. JK Chan, VC Sin, KF Wong, et al. (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89(12), 4501-4513.
219. JK Chan (1999) Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis. Mod Pathol 12(2), 177-199.
220. M Takeshita, M Akamatsu, K Ohshima, et al. (1995) CD30 (Ki-1) expression in adult T-cell leukaemia/lymphoma is associated with distinctive immunohistological and clinical characteristics. Histopathology 26(6), 539-546.
221. Q Tao, FC Ho, SL Loke, et al. (1995) Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer 60(3), 315-320.
222. PC de Bruin, M Jiwa, JJ Oudejans, et al. (1994) Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood 83(6), 1612-1618.
223. JC Sabourin, P Kanavaros, J Briere, et al. (1993) Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in non-immunocompromised patients. Am J Surg Pathol 17(10), 995-1002.
224. P Kanavaros, M Vlychou, K Stefanaki, et al. (1999) Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Anticancer Res 19(2A), 1209-1216.
225. ML Boulland, P Kanavaros, J Wechsler, et al. (1997) Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas. J Pathol 183(4), 432-439.
226. WR Macon, ME Williams, JP Greer, et al. (1996) Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 87(4), 1474-1483.
227. A Chott, M Vesely, I Simonitsch, et al. (1999) Classification of intestinal T-cell neoplasms and their differential diagnosis. Am J Clin Pathol 111(1 Suppl 1), S68-S74.
228. PC de Bruin, CE Connolly, JJ Oudejans, et al. (1997) Enteropathy-associated T-cell lymphomas have a cytotoxic T-cell phenotype. Histopathology 31(4), 313-317.
229. M Ilyas, G Niedobitek, A Agathanggelou, et al. (1995) Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma. J Pathol 177(2), 115-122.
230. MJ Carey, LJ Medeiros, JE Roepke, et al. (1999) Primary anaplastic large cell lymphoma of the small intestine. Am J Clin Pathol 112(5), 696-701.
231. A Murray, EC Cuevas, DB Jones, et al. (1995) Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 146(2), 509-519.
232. H Wu, MA Wasik, G Przybylski, et al. (2000) Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients. Am J Clin Pathol 113(4), 487-496.
233. CB Cooke, L Krenacs, M Stetler-Stevenson, et al. (1996) Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood 88(11), 4265-4274.
234. KE Salhany, WR Macon, JK Choi, et al. (1998) Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 22(7), 881-893.
235. S Kumar, L Krenacs, J Medeiros, et al. (1998) Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol 29(4), 397-403.
236. MC Kinney (1999) The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms. Am J Clin Pathol 111(1 Suppl 1), S104-S118.
237. K Chang and L Weiss (1994) CD7: a review. Appl Immunohistochem 2 146-156.
238. V Bakels, JW van Oostveen, SC van der Putte, et al. (1997) Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. Am J Pathol 150(6), 1941-1949.
239. LJ Picker, MB Brenner, LM Weiss, et al. (1987) Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas. Am J Pathol 129(3), 434-440.
240. D Bani and B Giannotti (1989) Differentiation of interdigitating reticulum cells and Langerhans cells in the human skin with T-lymphoid infiltrate. An immunocytochemical and ultrastructural study. Arch Histol Cytol 52(4), 361-372.
241. G Li, L Chooback, JT Wolfe, et al. (1998) Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol 110(5), 767-770.
242. W Kempf, R Dummer and G Burg (1999) Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol 111(1 Suppl 1), S84-S93.
243. J Krishnan, MM Tomaszewski and GF Kao (1993) Primary cutaneous CD30-positive anaplastic large cell lymphoma. Report of 27 cases. J Cutan Pathol 20(3), 193-202.
244. JA Kummer, MH Vermeer, D Dukers, et al. (1997) Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. J Invest Dermatol 109(5), 636-640.
245. ML Boulland, J Wechsler, M Bagot, et al. (2000) Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 36(2), 136-144.
246. B Vergier, M Beylot-Barry, K Pulford, et al. (1998) Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol 22(10), 1192-1202.
247. H Herbst, C Sander, M Tronnier, et al. (1997) Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol 137(5), 680-686.
248. RC Beljaards, P Kaudewitz, E Berti, et al. (1993) Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 71(6), 2097-2104.
249. P Brice, D Cazals, N Mounier, et al. (1998) Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte. Leukemia 12(2), 213-219.
250. I Anagnostopoulos, M Hummel, P Kaudewitz, et al. (1996) Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations. Br J Dermatol 134(2), 276-281.
251. CY Leung, FC Ho, G Srivastava, et al. (1993) Usefulness of follicular dendritic cell pattern in classification of peripheral T-cell lymphomas. Histopathology 23(5), 433-437.
252. I Anagnostopoulos, M Hummel, T Finn, et al. (1992) Heterogeneous Epstein-Barr virus infection patterns in peripheral T- cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80(7), 1804-1812.
253. B Nathwani and E Jaffe (1995) Angioimmunoblastic lymphadenopathy (AILD) and AILD-like T-cell lymphomas. E Jaffe (Eds) Surgical pathology of the lymph nodes and related organs 2nd edn Philadelphia: WB Saunders 390-412.
254. MJ Borowitz, S Newby, RK Brynes, et al. (1984) Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience. Blood 63(5), 1147-1152.
255. JG Strickler, LM Weiss, CM Copenhaver, et al. (1987) Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas. Hum Pathol 18(8), 808-814.
256. SJ Hamilton-Dutoit and G Pallesen (1992) A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol 140(6), 1315-1325.
257. ME Kadin (1994) Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 5(Suppl 1), 25-30.
258. PL Perkins, CW Ross and B Schnitzer (1992) CD30-positive, anaplastic large-cell lymphomas that express CD15 but lack CD45. A possible diagnostic pitfall. Arch Pathol Lab Med 116(11), 1192-1196.
259. W Biernat (1994) Ki-1-positive anaplastic large cell lymphoma: a morphologic and immunologic study of 14 cases. Patol Pol 45(1), 39-44.
260. P Brousset, P Rochaix, S Chittal, et al. (1993) High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 23(2), 189-191.
261. C Bayle, A Charpentier, E Duchayne, et al. (1999) Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases. Br J Haematol 104(4), 680-688.
262. MC Kinney, RD Collins, JP Greer, et al. (1993) A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 17(9), 859-868.
263. M Piris, DC Brown, KC Gatter, et al. (1990) CD30 expression in non-Hodgkin's lymphoma. Histopathology 17(3), 211-218.
264. RD Gascoyne, P Aoun, D Wu, et al. (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 93(11), 3913-3921.
265. KB Hodges, RD Collins, JP Greer, et al. (1999) Transformation of the small cell variant Ki-1+ lymphoma to anaplastic large cell lymphoma: pathologic and clinical features. Am J Surg Pathol 23(1), 49-58.
266. A Nakagawa, S Nakamura, M Ito, et al. (1997) CD30-positive anaplastic large cell lymphoma in childhood: expression of p80npm/alk and absence of Epstein-Barr virus. Mod Pathol 10(3), 210-215.
267. S Nakamura, M Shiota, A Nakagawa, et al. (1997) Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression. Am J Surg Pathol 21(12), 1420-1432.
268. HD Foss, I Anagnostopoulos, I Araujo, et al. (1996) Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88(10), 4005-4011.
269. HD Foss, G Demel, I Anagnostopoulos, et al. (1997) Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma. Pathobiology 65(2), 83-90.
270. L Krenacs, A Wellmann, L Sorbara, et al. (1997) Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 89(3), 980-989.
271. E Cesarman, G Inghirami, A Chadburn, et al. (1993) High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 143(3), 845-856.
272. G Inghirami, L Macri, E Cesarman, et al. (1994) Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation. Blood 83(12), 3581-3590.
273. M Fraga, P Brousset, D Schlaifer, et al. (1995) Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 103(1), 82-89.